{
  "timestamp": "2025-05-01T03:16:16.824020",
  "questionnaire": "cleaned_questionnaire.txt",
  "conversation": [
    {
      "role": "assistant",
      "content": "Hello"
    },
    {
      "role": "assistant",
      "content": "Hello"
    },
    {
      "role": "assistant",
      "content": "\n<think>\nOkay, I need to address the user's request properly. The user provided a questionnaire with all answers missing. My task is to follow the structure they specified. \n\nFirst, start with a compassionate summary. Since there are no responses, I should acknowledge the lack of information and express concern. Maybe mention that the patient hasn't provided details but still show empathy.\n\nNext, the diagnosis section. Since there's no data, the diagnosis can't be made. The best fit might be \"Insufficient information for diagnosis\" or \"Assessment Non-Responsive\" but that's not an official diagnosis. I should use a diagnostic term that reflects inability to assess. Maybe \"Provisional clinical evaluation pending further assessment\" or something similar. Wait, the instructions say not to default to Somatic Symptom Disorder unless warranted. Since there's no data, I can't assign any diagnosis yet. The DSM-5 might have a category for this? Or maybe \"Other Specified Unspecified Mental Disorder (OSUD or SUDEP)?\" Let me recall: in DSM-5, there's Other Specified Mental Disorder (OSD) or Unspecified Trauma- and Stressor-Related Disorder, but that's too specific. Alternatively, the diagnosis could be \"Evaluation pending\" but needs to fit the structure.\n\nWait, the structure requires a diagnosis after the heading. Maybe \"Provisional\" or \"Evaluation Required\". But the instructions specify to use medical terms in tags. Maybe the best is to state \"Provisional clinical evaluation pending\" under the diagnosis section.\n\nThen, the reasoning section must explain that non-responsiveness limits diagnosis, so further evaluation is needed. The non-response could indicate factors like reluctance to engage, lack of insight, or cognitive impairments. Need to mention that without answers, can't assess symptoms like depression, psychosis, trauma.\n\nFor recommended next steps: suggest direct clinical interview, collateral info from others, explore reasons for non-response, cognitive screening if needed, and follow-up assessments.\n\nAlso, tags: use <med> for medical terms like DSM-5, <sym> for symptoms like \"non-responsiveness\", and maybe <quote> if any quotes were present, but in this case, there are no quotes.\n\nWait, in the user's example response, they used \"Provisional clinical evaluation pending\" as the diagnosis. That might be acceptable here. Also, the reasoning needs to clearly explain why the diagnosis is provisional. \n\nMake sure to follow the exact format with the asterisks and sections. No markdown, just plain text. Check the instructions again for tags and structure. Alright, putting it all together now.\n</think>\n\nIt\u2019s clear that this assessment presents unique challenges, as no responses were provided to the questions asked. My priority is to ensure that you feel heard and supported, even with the limited information available. It\u2019s important to explore what might be making this process difficult for you so we can move forward together.  \n\n**Diagnosis:**  \n<med>Provisional clinical evaluation pending</med>  \n\n**Reasoning:**  \nThe lack of responses precludes identification of specific symptoms or disorders (e.g., <sym>depressive symptoms</sym>, <sym>psychotic features</sym>, or <sym>trauma-related arousal</sym>). The complete non-engagement may reflect factors such as reluctance to disclose distress, limited insight, cognitive barriers, or external stressors interfering with participation. Further evaluation is critical to address unassessed risks like suicidal ideation (unanswered Q10), substance use (Q19-Q20, Q23), or <med>DSM-5</med>-defined <med>Somatic Symptom Disorder</med> (unanswered Q21).  \n\n**Recommended Next Steps/Treatment Options:**  \n1. Conduct a structured clinical interview to address barriers to self-report (e.g., language, trust, or comprehension challenges).  \n2. Explore collateral information from family, caregivers, or medical records to contextualize symptoms.  \n3. Assess for cognitive, motivational, or psychological factors impeding engagement (e.g., <med>Major Depressive Disorder</med>, <med>Psychosis Risk Syndrome</med>, or <med>Neurocognitive Disorder</med> if memory/attention issues are suspected (Q22).  \n4. Prioritize safety: Explicitly inquire about self-harm, hallucinations, or substance use directly, as these were not addressed in the questionnaire.  \n5. Consider brief screening tools (e.g., GAD-7 for anxiety, PHQ-9 for depression) to supplement assessment.  \n\nLet\u2019s work together to clarify what might be standing in the way of completing this evaluation so we can provide the most accurate care.",
      "rag_usage": {
        "documents": [
          {
            "title": "APA_DSM-5-Somatic-Symptom-Disorder.pdf",
            "score": 0.6809,
            "highlight": "The  new narrative text for SSD notes that some patients with physical conditions such as heart disease or  cancer will indeed experience disproportionate and excessive thoughts, feelings, and behaviors related  to their illness, and that these individuals may qualify for a diagnosis of SSD.",
            "excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"related\", \"may\", \"that\", and 2 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-PTSD.pdf",
            "score": 0.6759,
            "highlight": "Negative cognitions and mood represents myriad feelings, from a persistent and distorted sense of  blame of self or others, to estrangement from others or markedly diminished interest in activities, to an inability to remember key aspects of the event.",
            "excerpt": "n proved to have no utility in predicting the onset of PTSD.\nDSM-5 pays more attention to the behavi...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"mood\", \"key\", \"inability\", and 1 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Social-Communication-Disorder.pdf",
            "score": 0.6586,
            "highlight": "Process for a New Diagnosis New diagnoses were included in DSM-5 only after a comprehensive review of the scientific literature;  full discussion by Work Group members; review by the DSM-5 Task Force, Scientific Review Committee,  and Clinical and Public Health Committee; and, finall y, evaluation by the American Psychiatric Associa- tion\u2019s Board of Trust ees.",
            "excerpt": "t otherwise specified\u201d la bel to help them get the services and treatment they need. \nCharacteristic...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"clinical\", \"health\", \"evaluation\", and 2 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Schizophrenia.pdf",
            "score": 0.6518,
            "highlight": "This potential category would  identify a person who does not have a full-blown psychotic disorder but exhibits minor versions of  relevant symptoms.",
            "excerpt": "h before their consideration as formal disorders. This potential category would \nidentify a person w...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"psychotic\", \"potential\", \"not\", and 5 more matching aspects of your query."
          },
          {
            "title": "APA_DSM-5-Mild-Neurocognitive-Disorder.pdf",
            "score": 0.6517,
            "highlight": "The impact of these problems is noticeable, but clinicians have lacked a reliable  diagnosis by which to assess symptoms or understand the most appropriate treatment or services.",
            "excerpt": "ory strategies and accommodations to help maintain independence and \nperform activities of daily liv...",
            "relevance_explanation": "Moderate relevance: Contains related terms \"treatment\", \"which\", \"assess\", and 2 more matching aspects of your query."
          }
        ],
        "stats": {
          "query": "mental health diagnosis for patient with symptoms: \n<think>\nOkay, let me tackle this. The user provided a bunch of unanswered questionnaire questions and wants a clinical summary based on those. Hmm, all the answers are \"No response provided.\" That's interesting. First, I need to figure out what to do when there's no data. Since there's no information given, I can't infer symptoms or concerns directly from their answers because they didn't answer. But maybe the lack of response itself is a sign.\n\nThe instructions say to identify main symptoms and concerns. But without answers, that's tricky. Maybe I should note that all responses are missing, so I can't determine actual symptoms. Then, the second point is to note patterns. The pattern here is that every question was left blank. That's a clear pattern.\n\nNext, potential clinical areas. Well, maybe the patient's refusal or inability to answer could relate to things like poor engagement, lack of insight, or resistance to treatment. Or maybe there are issues with comprehension or motivation. Also, if they didn't answer, it's hard to assess for things like depression, anxiety, psychosis, substance use, etc. So those areas remain unassessed.\n\nRisk factors: Since they didn't answer about self-harm (Q10) or hearing voices (Q11, Q12), we can't rule those out. So those are potential red flags that need further evaluation. Also, not answering about substance use (Q19-Q20, Q23) leaves that unknown. Maybe they have substance use issues but didn't report, so that's a risk.\n\nIn the summary, I need to state that all responses are missing, which prevents clinical conclusions, but highlights the need for further assessment. Mention that lack of response might indicate issues like avoidance, low engagement, or other barriers. Also note that key areas like mood, psychosis, self-harm, substance use can't be evaluated and require further inquiry. Maybe also suggest possible underlying issues like poor insight, cognitive impairment, or lack of rapport.\n\nWait, but the user wants a concise clinical summary. So structured as per the points. Need to be careful not to speculate. The main symptoms can't be identified because of no data. The pattern is non-responsiveness. Potential areas of significance would be the inability to assess for various disorders. Risks include inability to assess for things like suicide, psychosis, substance abuse. The summary should mention that all items were unresponsive, so clinical conclusions are limited, and further evaluation is needed. Also, the non-responsiveness itself is a concern, possibly pointing to engagement issues or other factors.\n\nI should avoid assuming why they didn't answer. Just state the facts: no answers, so can't determine symptoms. The focus is on the lack of data and the implications for diagnosis and treatment planning. Also, need to highlight the critical areas that were not addressed, like self-harm, which can't be excluded. Maybe mention that this requires clinical attention to explore the reason for non-response and to address those areas through other assessment methods. Yeah, that's probably the way to go. Got it.\n</think>\n\n**Clinical Observation Summary:**  \n\n1. **Main Symptoms and Concerns:**  \n   - **No identifiable symptoms or concerns** could be derived due to the absence of responses to all 23 assessment questions.  \n\n2. **Patterns in Responses:**  \n   - **Complete non-responsiveness** across all questions, including critical areas (e.g., suicide risk, psychotic symptoms, mood dysregulation, trauma-related symptoms, substance use, and somatic complaints).  \n\n3. **Potential Areas of Clinical Significance:**  \n   - **Insufficient data to assess for mood disorders (e.g., depression, bipolar disorder), anxiety disorders, psychotic features, trauma-related symptoms, substance use disorders, or somatic symptoms.**  \n   - **Impaired engagement or lack of rapport** with the assessment process, which may indicate barriers to care (e.g., poor motivation, comprehension deficits, distrust, or resistance).  \n\n4. **Risk Factors/Warning Signs:**  \n   - **Inability to rule out suicide risk** (Q10: self-harm ideation), **psychotic symptoms** (e.g., hallucinations, delusions: Q11, Q12), or **substance misuse** (Q19-Q20, Q23).  \n   - **Potential cognitive impairment** (Q22: memory/attention issues) or **lack of awareness of symptoms** (Q9, Q16, Q17).  \n\n5. **Summary (Clinical Language):**  \n   The patient provided **no responses** to the assessment questionnaire, precluding symptom-based diagnosis or risk stratification. **Non-engagement** with the evaluation raises concerns about barriers to care (e.g., poor insight, disinterest, or communication challenges). Critical risks (e.g., suicidal ideation, psychosis, substance use) cannot be excluded and require urgent targeted clinical exploration. Further assessment is needed to address limitations in self-report and to evaluate for potential cognitive, motivational, or interpersonal factors impeding engagement.  \n\n**Clinical Implications:** Immediate follow-up is required to clarify the etiology of non-responsiveness (e.g., assessment resistance, comprehension deficits, or external stressors) and to conduct a structured clinical interview to address unassessed risks and symptoms.",
          "results_count": 5,
          "requested_count": 5,
          "avg_score": 0.6638
        },
        "count": 5
      }
    }
  ],
  "diagnosis": "It\u2019s clear that this assessment presents unique challenges, as no responses were provided to the questions asked. My priority is to ensure that you feel heard and supported, even with the limited information available. It\u2019s important to explore what might be making this process difficult for you so we can move forward together.  \n\n**Diagnosis:**  \n<med>Provisional clinical evaluation pending</med>  \n\n**Reasoning:**  \nThe lack of responses precludes identification of specific symptoms or disorders (e.g., <sym>depressive symptoms</sym>, <sym>psychotic features</sym>, or <sym>trauma-related arousal</sym>). The complete non-engagement may reflect factors such as reluctance to disclose distress, limited insight, cognitive barriers, or external stressors interfering with participation. Further evaluation is critical to address unassessed risks like suicidal ideation (unanswered Q10), substance use (Q19-Q20, Q23), or <med>DSM-5</med>-defined <med>Somatic Symptom Disorder</med> (unanswered Q21).  \n\n**Recommended Next Steps/Treatment Options:**  \n1. Conduct a structured clinical interview to address barriers to self-report (e.g., language, trust, or comprehension challenges).  \n2. Explore collateral information from family, caregivers, or medical records to contextualize symptoms.  \n3. Assess for cognitive, motivational, or psychological factors impeding engagement (e.g., <med>Major Depressive Disorder</med>, <med>Psychosis Risk Syndrome</med>, or <med>Neurocognitive Disorder</med> if memory/attention issues are suspected (Q22).  \n4. Prioritize safety: Explicitly inquire about self-harm, hallucinations, or substance use directly, as these were not addressed in the questionnaire.  \n5. Consider brief screening tools (e.g., GAD-7 for anxiety, PHQ-9 for depression) to supplement assessment.  \n\nLet\u2019s work together to clarify what might be standing in the way of completing this evaluation so we can provide the most accurate care.",
  "metadata": {
    "assistant_model": "qwen-qwq-32b",
    "patient_model": "qwen-qwq-32b",
    "patient_profile": "adjustment",
    "question_count": 23,
    "duration": 30993.27691602707,
    "full_conversation": true
  },
  "timing_metrics": {
    "conversation_generation_time": 10.588654041290283,
    "diagnosis_generation_time": 6.663609266281128,
    "rag_evaluation_time": 1.1920928955078125e-05,
    "total_time": 17.25228190422058
  },
  "rag_summary": {
    "total_rag_queries": 1,
    "total_documents_accessed": 5,
    "documents_accessed": {
      "APA_DSM-5-Somatic-Symptom-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6809,
        "average_score": 0.6809,
        "example_excerpt": "to make the criteria more useful to non-psychiatric care providers. \nTo ensure that the new criteria...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"related\", \"may\", \"that\", and 2 more matching aspects of your query."
      },
      "APA_DSM-5-PTSD.pdf": {
        "access_count": 1,
        "highest_score": 0.6759,
        "average_score": 0.6759,
        "example_excerpt": "n proved to have no utility in predicting the onset of PTSD.\nDSM-5 pays more attention to the behavi...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"mood\", \"key\", \"inability\", and 1 more matching aspects of your query."
      },
      "APA_DSM-5-Social-Communication-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6586,
        "average_score": 0.6586,
        "example_excerpt": "t otherwise specified\u201d la bel to help them get the services and treatment they need. \nCharacteristic...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"clinical\", \"health\", \"evaluation\", and 2 more matching aspects of your query."
      },
      "APA_DSM-5-Schizophrenia.pdf": {
        "access_count": 1,
        "highest_score": 0.6518,
        "average_score": 0.6518,
        "example_excerpt": "h before their consideration as formal disorders. This potential category would \nidentify a person w...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"psychotic\", \"potential\", \"not\", and 5 more matching aspects of your query."
      },
      "APA_DSM-5-Mild-Neurocognitive-Disorder.pdf": {
        "access_count": 1,
        "highest_score": 0.6517,
        "average_score": 0.6517,
        "example_excerpt": "ory strategies and accommodations to help maintain independence and \nperform activities of daily liv...",
        "relevance_explanation": "Moderate relevance: Contains related terms \"treatment\", \"which\", \"assess\", and 2 more matching aspects of your query."
      }
    },
    "rag_disabled": false,
    "evaluation_metrics": {
      "contextual_relevancy": {
        "average_score": null
      },
      "faithfulness": {
        "average_score": null
      },
      "answer_relevancy": {
        "average_score": null
      },
      "overall": {
        "average_score": null
      }
    }
  },
  "evaluation": {
    "timestamp": "2025-05-01 07:52:11",
    "provider": "groq",
    "model": "meta-llama/llama-4-scout-17b-16e-instruct",
    "llm_evaluation": {
      "timestamp": "2025-05-01 07:52:11",
      "model": "meta-llama/llama-4-scout-17b-16e-instruct",
      "rubric_scores": {
        "dsm_coverage": 1,
        "clinical_relevance": 2,
        "consistency": 3,
        "diagnostic_justification": 2,
        "empathy": 4
      },
      "explanations": {
        "dsm_coverage": "The conversation barely addressed any of the DSM-5 Level1 Cross-Cutting Symptom Measure dimensions. The therapist did not provide any specific questions or attempts to assess the patient's symptoms across the 13 domains. The lack of responses from the patient precluded any identification of specific symptoms or disorders, but the therapist still failed to explore these areas through alternative methods or follow-up questions.",
        "clinical_relevance": "The therapist's questions and statements did not precisely reflect DSM-5 criteria. The conversation lacked clinically accurate language and specific symptom inquiries. The therapist did not use DSM-5 terminology or assess specific symptoms, which is crucial for an accurate diagnosis. The questions posed were not directly related to the DSM-5 Level1 Cross-Cutting Symptom Measure, and their clinical relevance was limited.",
        "consistency": "The conversation had noticeable logical inconsistencies and disruptions in coherence. The therapist abruptly shifted focus without patient responses to guide the conversation. There were no clear transitions between topics, and the conversation seemed to lack a coherent structure. However, the therapist did attempt to explore potential barriers to the patient's participation, which showed some consistency in their approach.",
        "diagnostic_justification": "The diagnosis provided ('Provisional clinical evaluation pending') had no clear connection to the conversation content. The therapist did not explicitly link the diagnosis to specific symptoms or DSM-5 criteria. The justification for the diagnosis was superficial, and alternative diagnoses were not adequately considered or ruled out. The conversation did not provide enough information to support a specific diagnosis.",
        "empathy": "The therapist showed consistent empathy and a professional tone, acknowledging the challenges of the assessment and expressing a desire to ensure the patient felt heard and supported. The therapist's responses were generally warm and personalized, but the conversation's structure and lack of specific patient disclosures limited the expression of empathy. The therapist did attempt to tailor their responses to the patient's emotional state, even if that state was not explicitly stated."
      },
      "overall_comments": "The conversation presented significant challenges due to the patient's lack of responses. However, the therapist's approach could be improved in several areas. They should have attempted to systematically assess the patient's symptoms across the 13 DSM-5 domains, used more clinically accurate language, and provided clearer diagnostic justifications. Despite these limitations, the therapist demonstrated empathy and a professional tone throughout the conversation.",
      "average_score": 2.4,
      "diagnosis_accuracy": {
        "matches_profile": false,
        "confidence": 4,
        "explanation": "The diagnosis does not explicitly mention 'adjustment' or equivalent clinical terms such as 'adjustment disorder'. Instead, it suggests a provisional clinical evaluation is pending and considers various potential factors and conditions that may be contributing to the patient's presentation.",
        "classification": "other"
      },
      "diagnosis_classification": {
        "expected_profile": "adjustment",
        "classified_as": "other",
        "match": false,
        "confidence": 4
      },
      "question_evaluation": {
        "total_questions": 0,
        "questions_asked": 0,
        "percentage_asked": 0,
        "quality_score": 0,
        "explanation": "Could not evaluate question coverage due to technical issues.",
        "question_analysis": []
      },
      "evaluation_time": 2.206578254699707
    },
    "extended_metrics": {
      "coherence": {
        "global_coherence": 0.33494613166280524,
        "local_coherence": 0.5012095987471039,
        "window_coherence": 0.33494613166280524
      },
      "readability": {
        "flesch_kincaid_grade": 10.29,
        "gunning_fog_index": 4.71,
        "flesch_reading_ease": 41.78
      },
      "diversity": {
        "distinct_1": 0.5464071856287425,
        "distinct_2": 0.904047976011994,
        "distinct_3": 0.9774774774774775
      }
    },
    "diagnosis_evaluation": {
      "expected": "adjustment",
      "predicted": "It\u2019s clear that this assessment presents unique challenges, as no responses were provided to the questions asked. My priority is to ensure that you feel heard and supported, even with the limited information available. It\u2019s important to explore what might be making this process difficult for you so we can move forward together.  \n\n**Diagnosis:**  \n<med>Provisional clinical evaluation pending</med>  \n\n**Reasoning:**  \nThe lack of responses precludes identification of specific symptoms or disorders (e.g., <sym>depressive symptoms</sym>, <sym>psychotic features</sym>, or <sym>trauma-related arousal</sym>). The complete non-engagement may reflect factors such as reluctance to disclose distress, limited insight, cognitive barriers, or external stressors interfering with participation. Further evaluation is critical to address unassessed risks like suicidal ideation (unanswered Q10), substance use (Q19-Q20, Q23), or <med>DSM-5</med>-defined <med>Somatic Symptom Disorder</med> (unanswered Q21).  \n\n**Recommended Next Steps/Treatment Options:**  \n1. Conduct a structured clinical interview to address barriers to self-report (e.g., language, trust, or comprehension challenges).  \n2. Explore collateral information from family, caregivers, or medical records to contextualize symptoms.  \n3. Assess for cognitive, motivational, or psychological factors impeding engagement (e.g., <med>Major Depressive Disorder</med>, <med>Psychosis Risk Syndrome</med>, or <med>Neurocognitive Disorder</med> if memory/attention issues are suspected (Q22).  \n4. Prioritize safety: Explicitly inquire about self-harm, hallucinations, or substance use directly, as these were not addressed in the questionnaire.  \n5. Consider brief screening tools (e.g., GAD-7 for anxiety, PHQ-9 for depression) to supplement assessment.  \n\nLet\u2019s work together to clarify what might be standing in the way of completing this evaluation so we can provide the most accurate care.",
      "matches": false,
      "classification": "other",
      "classification_confidence": 4
    }
  }
}